A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.

Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer ...

Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving for 5 years or more after initial diagnosis. Early detection of PC is the ...

Due to a lack of noticeable symptoms in its early stages and the pancreas’ obscure location behind other organs in the ...

The discovery of a 'biomarker panel' could have a profound impact on the ability to identify patients at risk of developing ...

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

Researchers at Oregon Health and Science University (OHSU) have developed a blood test called PAC-MANN, to detect pancreatic ...

Pancreatic cancer is often discovered in advanced stages because it doesn’t usually cause symptoms until it has spread to other organs, limiting treatment options. The American Cancer Society ...

New blood test PAC-MANN detects pancreatic cancer early with 98% accuracy, offering hope for improved survival rates.

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced that the New York State Department of Health (NYSDOH) Clinical Laboratory Evaluation ...